BIOTON SA (BIO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BIOTON SA

Biogened SA

Ryvu Therapeutics SA

Celon Pharma SA

Captor Therapeutics SA

Synthaverse SA

Bioceltix SA

Molecure SA

NanoGroup SA

E-shopping Group SA

Airway Medix SA

Why is BIOTON SA ?

The company has declared positive results in Jan 70 after 4 consecutive negative quarters

NET SALES(HY) At PLN 152.51 MM has Grown at 64.71%
DEBT-EQUITY RATIO (HY) Lowest at 7.05 %
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost

With ROE of -0.45%, it has a risky valuation with a 0.60 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 5.83%, its profits have risen by 54%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to BIOTON SA should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is BIOTON SA for you?

Low Risk, Medium Return

Absolute

Risk Adjusted

Volatility

BIOTON SA

-100.0%

1.18

20.91%

Poland WIG

27.26%

1.56

17.47%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.87%

EBIT Growth (5y)

52.69%

EBIT to Interest (avg)

1.41

Debt to EBITDA (avg)

1.46

Net Debt to Equity (avg)

0.06

Sales to Capital Employed (avg)

0.34

Tax Ratio

29.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.00%

ROE (avg)

1.05%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.60

EV to EBIT

27.44

EV to EBITDA

7.38

EV to Capital Employed

0.62

EV to Sales

1.30

PEG Ratio

Dividend Yield

ROCE (Latest)

2.26%

ROE (Latest)

-0.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

32What is working for the Company

NET SALES(HY)

At PLN 152.51 MM has Grown at 64.71%

DEBT-EQUITY RATIO (HY)

Lowest at 7.05 %

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -4.92% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.99 times

DEBTORS TURNOVER RATIO(HY)

Highest at 8.84 times

OPERATING PROFIT(Q)

Highest at PLN 17.64 MM

OPERATING PROFIT MARGIN(Q)

Highest at 24.28 %

PRE-TAX PROFIT(Q)

Highest at PLN 6.28 MM

NET PROFIT(Q)

Highest at PLN 4.35 MM

EPS(Q)

Highest at PLN 0.05

-1What is not working for the Company

CASH AND EQV(HY)

Lowest at PLN 3.02 MM

Here's what is working for BIOTON SA

Pre-Tax Profit

At PLN 6.28 MM has Grown at 634.24%

over average net sales of the previous four periods of PLN -1.17 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (PLN MM)

Net Profit

At PLN 4.35 MM has Grown at 267.53%

over average net sales of the previous four periods of PLN -2.6 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (PLN MM)

Net Sales

At PLN 152.51 MM has Grown at 64.71%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (PLN MM)

Debt-Equity Ratio

Lowest at 7.05 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Profit

Highest at PLN 17.64 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (PLN MM)

Operating Profit Margin

Highest at 24.28 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at PLN 6.28 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (PLN MM)

Net Profit

Highest at PLN 4.35 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (PLN MM)

EPS

Highest at PLN 0.05

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (PLN)

Inventory Turnover Ratio

Highest at 1.99 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 8.84 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -4.92% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for BIOTON SA

Cash and Eqv

Lowest at PLN 3.02 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents